MX2017004899A - Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos. - Google Patents

Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos.

Info

Publication number
MX2017004899A
MX2017004899A MX2017004899A MX2017004899A MX2017004899A MX 2017004899 A MX2017004899 A MX 2017004899A MX 2017004899 A MX2017004899 A MX 2017004899A MX 2017004899 A MX2017004899 A MX 2017004899A MX 2017004899 A MX2017004899 A MX 2017004899A
Authority
MX
Mexico
Prior art keywords
derived
mammals
pyrazoline
joint disease
degenerative joint
Prior art date
Application number
MX2017004899A
Other languages
English (en)
Inventor
Homedes- Beguer Josep
Sabate- Elias David
Original Assignee
Ecuphar N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecuphar N V filed Critical Ecuphar N V
Publication of MX2017004899A publication Critical patent/MX2017004899A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al uso de los compuestos E-6087 en una pauta posológica semanal para el tratamiento de dolor e inflamación asociados a una enfermedad articular degenerativa tal como artrosis o una afección asociada a cualquier dicha enfermedad tal como cojera. La presente invención se refiere al tratamiento de mamíferos, preferentemente perros.
MX2017004899A 2014-10-16 2015-10-13 Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos. MX2017004899A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14382396.1A EP3009137A1 (en) 2014-10-16 2014-10-16 Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals
PCT/EP2015/073635 WO2016059028A1 (en) 2014-10-16 2015-10-13 Pyrazoline-derived compound and its use in a weekly dosage regime against inflammation and pain derived from degenerative joint disease in mammals

Publications (1)

Publication Number Publication Date
MX2017004899A true MX2017004899A (es) 2018-02-12

Family

ID=51844648

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004899A MX2017004899A (es) 2014-10-16 2015-10-13 Compuestos derivado de pirazolina y su uso en una pauta posológica semanal contra la inflamación y el dolor derivados de la enfermedad articular degenerativa en mamíferos.

Country Status (19)

Country Link
US (1) US11154536B2 (es)
EP (2) EP3009137A1 (es)
JP (1) JP6655625B2 (es)
CN (2) CN107257684A (es)
AR (1) AR102295A1 (es)
CA (1) CA2964428C (es)
CY (1) CY1123243T1 (es)
DK (1) DK3206684T3 (es)
ES (1) ES2828435T3 (es)
HR (1) HRP20201233T1 (es)
HU (1) HUE050511T2 (es)
LT (1) LT3206684T (es)
MX (1) MX2017004899A (es)
PL (1) PL3206684T3 (es)
PT (1) PT3206684T (es)
RS (1) RS60777B1 (es)
SI (1) SI3206684T1 (es)
TW (1) TWI707678B (es)
WO (1) WO2016059028A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109303784B (zh) * 2018-09-30 2020-06-23 山东省文登整骨医院 痛风性关节炎动物模型的构建方法
EP4029502A1 (en) 2021-01-15 2022-07-20 Ecuphar N.V. Pyrazoline-derived compound (enflicoxib) for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU773615B2 (en) * 1997-05-05 2004-05-27 Pfizer Inc. COX-2 selective carprofen for treating pain and inflammation in dogs
ES2137138B1 (es) * 1998-05-29 2000-09-16 Esteve Labor Dr Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
US20050131028A1 (en) * 2003-09-11 2005-06-16 Pharmacia Corporation Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
BRPI0607985A2 (pt) * 2005-03-10 2009-10-27 Genentech Inc modulador da dscr1, métodos de tratamento, método de melhoria de efeitos colaterais e método de inibição do crescimento de tumores

Also Published As

Publication number Publication date
PT3206684T (pt) 2020-08-24
EP3206684B1 (en) 2020-06-17
CA2964428C (en) 2022-01-04
US11154536B2 (en) 2021-10-26
WO2016059028A1 (en) 2016-04-21
CA2964428A1 (en) 2016-04-21
AR102295A1 (es) 2017-02-15
HRP20201233T1 (hr) 2020-11-13
CN107257684A (zh) 2017-10-17
DK3206684T3 (da) 2020-08-10
CY1123243T1 (el) 2021-10-29
RS60777B1 (sr) 2020-10-30
EP3009137A1 (en) 2016-04-20
US20170231961A1 (en) 2017-08-17
HUE050511T2 (hu) 2020-12-28
ES2828435T3 (es) 2021-05-26
SI3206684T1 (sl) 2020-11-30
CN115154465A (zh) 2022-10-11
JP2017531042A (ja) 2017-10-19
JP6655625B2 (ja) 2020-02-26
PL3206684T3 (pl) 2021-01-11
TWI707678B (zh) 2020-10-21
LT3206684T (lt) 2020-10-12
EP3206684A1 (en) 2017-08-23
TW201625239A (zh) 2016-07-16

Similar Documents

Publication Publication Date Title
PH12016501966B1 (en) Compounds and compositions as toll-like receptor 7 agonists
EP3180009A4 (en) Zoledronic acid dosage forms for the treatment of pain
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
EA201691845A1 (ru) Фармацевтические композиции терапевтически активных соединений
TW201613901A (en) New compounds
GB2541571A (en) Pharmaceutical compositions
NZ724878A (en) Compounds and compositions as toll-like receptor 7 agonists
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
EA201691844A1 (ru) Фармацевтические композиции терапевтически активных соединений
PH12018501227A1 (en) Drug for preventing and/or treating polycystic kidney disease
PH12016500356A1 (en) Nsaid and sigma receptor ligand combinations
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
EA201692470A1 (ru) Фармацевтические комбинации
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
MX2019006863A (es) Inhibidores de heparanasa y uso de los mismos.
PH12017500910A1 (en) Use of sigma receptor ligands in osteoarthritis
CY1123243T1 (el) Ενωση προερχομενη απο πυραζολινη και η χρηση τησσε ενα θεραπευτικο σχημα εβδομαδιαιας δοσολογησης εναντια στην φλεγμονη και τον πονο που προερχονται απο την εκφυλιστικη ασθενεια των αρθρωσεων στα θηλαστικα
MX370436B (es) Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica.
EA201791450A1 (ru) 3,5-диаминопиразоловые ингибиторы киназы
MX2018004532A (es) Combinacion de trazodona y gabapentina para el tratamiento de dolor.
AU2014353885A8 (en) Prevention and treatment of toxicosis
EA201401235A1 (ru) Композиция, содержащая глюкозамин, фруктобарат кальция и витамин d для лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов, её применение и способ лечения и/или профилактики нарушений, связанных с воспалительными заболеваниями суставов и позвоночника

Legal Events

Date Code Title Description
FG Grant or registration